Publications by authors named "Gabriel Mak"

Claim this Profile
D
Durvalumab in combination with chemoradiotherapy in patients with head and neck squamous cell carcinoma: Results from the Phase 1 CLOVER study.
Julie E Bauman, Sana D Karam, Cathy O'Brien, Gabriel Mak, Byoung Chul Cho

Head Neck· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Rationale for a Phase III, Randomized, Placebo-controlled Trial of Durvalumab With or Without Tremelimumab After Concurrent Chemoradiotherapy for Patients With Limited-stage Small-cell Lung Cancer: The ADRIATIC Study.
Suresh Senan, Isamu Okamoto, Gyeong-Won Lee, Yuanbin Chen, Seiji Niho, Gabriel Mak

Clin Lung Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours.
Gabriel Mak, Jean-Charles Soria, Sarah P Blagden, Ruth Plummer, Ronald A Fleming

Br J Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective analysis of 895 patients on a UK Genomics Review Board.
David Allan Moore, Marina Kushnir, Gabriel Mak, Helen Winter, Teresa Curiel

ESMO Open· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 Blockade.
Michele Moschetta, Mario Uccello, Benjamin Kasenda, Gabriel Mak, Anissa McClelland

Biomed Res Int· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients with BRAF V600-mutant tumours.
Noelia Nebot, Hendrik-Tobias Arkenau, Jeffrey R Infante, Jason C Chandler, Andrew Weickhardt, Gabriel Mak

Br J Clin Pharmacol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancer.
Michele Moschetta, Gabriel Mak, Joana Hauser, Catriona Davies, Mario Uccello

Exp Hematol Oncol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study.
Emily Y He, Nicholas J Hawkins, Gabriel Mak, Felicia Roncolato, David Goldstein

Oncologist· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment.
Gabriel Mak, Hendrik-Tobias Arkenau, Melvin Chin

Melanoma Res· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous metastasis of prostate carcinoma treated with radiotherapy: a case presentation.
Gabriel Mak, Melvin Chin, Najmun Nahar, Paul De Souza

BMC Res Notes· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of neostigmine in capecitabine-induced paralytic ileus.
Gabriel Mak, Robyn Ward, Yahya Shehabi, Ramya Venkateswaran, Melvin Chin

Tumori· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis